Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Facial neuromuscular junctions and brainstem nuclei are the target of tetanus neurotoxin in cephalic tetanus
Federico Fabris, … , Cesare Montecucco, Marco Pirazzini
Federico Fabris, … , Cesare Montecucco, Marco Pirazzini
Published May 9, 2023
Citation Information: JCI Insight. 2023;8(11):e166978. https://doi.org/10.1172/jci.insight.166978.
View: Text | PDF
Research Article Neuroscience

Facial neuromuscular junctions and brainstem nuclei are the target of tetanus neurotoxin in cephalic tetanus

  • Text
  • PDF
Abstract

Cephalic tetanus (CT) is a severe form of tetanus that follows head wounds and the intoxication of cranial nerves by tetanus neurotoxin (TeNT). Hallmarks of CT are cerebral palsy, which anticipates the spastic paralysis of tetanus, and rapid evolution of cardiorespiratory deficit even without generalized tetanus. How TeNT causes this unexpected flaccid paralysis, and how the canonical spasticity then rapidly evolves into cardiorespiratory defects, remain unresolved aspects of CT pathophysiology. Using electrophysiology and immunohistochemistry, we demonstrate that TeNT cleaves its substrate vesicle-associated membrane protein within facial neuromuscular junctions and causes a botulism-like paralysis overshadowing tetanus spasticity. Meanwhile, TeNT spreads among brainstem neuronal nuclei and, as shown by an assay measuring the ventilation ability of CT mice, harms essential functions like respiration. A partial axotomy of the facial nerve revealed a potentially new ability of TeNT to undergo intra-brainstem diffusion, which allows the toxin to spread to brainstem nuclei devoid of direct peripheral efferents. This mechanism is likely to be involved in the transition from local to generalized tetanus. Overall, the present findings suggest that patients with idiopathic facial nerve palsy should be immediately considered for CT and treated with antisera to block the potential progression to a life-threatening form of tetanus.

Authors

Federico Fabris, Stefano Varani, Marika Tonellato, Ivica Matak, Petra Šoštarić, Patrik Meglić, Matteo Caleo, Aram Megighian, Ornella Rossetto, Cesare Montecucco, Marco Pirazzini

×

Figure 2

TeNT cleaves its target VAMP at motor axon terminals of the WP in mice.

Options: View larger image (or click on image) Download as PowerPoint
TeNT cleaves its target VAMP at motor axon terminals of the WP in mice.
...
Confocal images of WP musculature from (A) naive and TeNT-treated mice (B) contralateral or (C) ipsilateral to injection at indicated times after injection; the red signal indicates the cleavage of VAMP at the NMJ identified through the labeling of nicotinic acetylcholine receptors (AChR, shown in green) with fluorescent α-bungarotoxin; insets show a 5× original magnification (A and C) and 3× original magnification in B. (D) Confocal images showing colocalization between cl-VAMP (red) and the vesicular transporter of acetylcholine (VAChT, green), a protein marker of synaptic vesicles, as expected from TeNT cleavage of VAMP on synaptic vesicles at the motor axon terminal; scale bar, 50 μm. (E) Quantification reporting the percentage of NMJs positive for the signal of cl-VAMP in the ipsilateral WP at indicated time points after TeNT injection compared with the contralateral at day 1. Data are expressed as means ± SD; ***P < 0.001; ****P < 0.0001 assessed by 1-way ANOVA with Bonferroni’s test. Black circles indicate the number of animals used in the experiment.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts